Literature DB >> 30997762

Genetic evaluation of bovine papillomavirus types detected in equine sarcoids in Poland.

A Szczerba-Turek1, J Siemionek1, A Ras2, A Bancerz-Kisiel1, A Platt-Samoraj1, K Lipczynska-Ilczuk1, W Szweda1.   

Abstract

BACKGROUND: Equine sarcoids are the most common neoplasms in horses. Bovine papilloma- virus type 1 (BPV-1) is the main viral type identified in equine sarcoids in Europe.
OBJECTIVE: The aim of the present study was to genetically evaluate BPV types based on DNA analyses of the CDS of the L1 gene. The presence of BPV DNA was confirmed by Degenerate Oligonucleotide-Primed Polymerase Chain Reaction (DOP PCR) with FAP59/FAP64 consensus primers.
RESULTS: The DNA was detected in 21/40 (52.5%) of clinically diagnosed sarcoids. More than half of 14 isolates (66.7%) shared 100% homology with BPV-1 Deltapapillomavirus 4 isolate 09 asi UK (Acc. No. MF384289) and 99% nucleotide identity with BPV-1 isolate EqSarc1 (Acc. No. JX678969). A comparison with BPV-1 isolate EqSarc1 revealed one silent mutation in C5827T which did not change the aminoacid codon. The remaining 6 isolates (28.6%) shared 100% nucleotide identity with the BPV-1 (Acc. No. X02346) "wild type" isolate, and 1 isolate (4.8%) demonstrated 99% nucleotide identity with BPV-2 (Acc. No. M20219).
CONCLUSIONS: Variants of BPV-1 isolate EqSarc1 (Acc. No. JX678969) constitute the most prevalent type of BPV-1 in Polish horses. Copyright© by the Polish Academy of Sciences.

Entities:  

Keywords:  FAP59/FAP64; bovine papillomavirus; disease ecology; equine sarcoid

Mesh:

Substances:

Year:  2019        PMID: 30997762     DOI: 10.24425/pjvs.2018.125602

Source DB:  PubMed          Journal:  Pol J Vet Sci        ISSN: 1505-1773            Impact factor:   0.821


  1 in total

1.  First detection and complete genome analysis of the Lyon IARC polyomavirus in China from samples of diarrheic cats.

Authors:  Yuying Li; Haixin Huang; Tian Lan; Wei Wang; Jie Zhang; Min Zheng; Liang Cao; Wenchao Sun; Huijun Lu
Journal:  Virus Genes       Date:  2021-05-10       Impact factor: 2.332

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.